Navigation Links
Lexi-Comp, Inc. Receives Weatherhead 100 Honor
Date:12/29/2009

Hudson company is recognized as one of Northeast Ohio's fastest growing companies

Hudson, OH (PRWEB) December 29, 2009 -- Lexi-Comp, Inc., a leader in providing drug and clinical information for healthcare professionals and health information systems, has received the ranking of 80 on the 2009 Weatherhead 100 list that showcases the fastest growing companies in Northeast Ohio. Qualifying companies must show consistent growth over the last five years and a strong entrepreneurial spirit that provides economic leadership in the local area. The Weatherhead 100 list, established in 1987, is highly regarded throughout the region and awards organizations for their hard work, commitment to excellence, and drive to succeed. Winners are objectively determined annually using a ranking system developed by the Weatherhead School of Management at Case Western Reserve University.

Lexi-Comp, a Hudson-based, privately-owned company, was founded in 1978 and has grown from a start-up company producing printed laboratory manuals to a provider of drug reference and clinical decision support information delivered electronically to healthcare professionals around the globe. Chairman and founder, Robert D. Kerscher, built the business with a strong focus on providing exceptional customer service, listening to client feedback, and responding to the marketplace by delivering an exceptional product. This philosophy has served the company well and has been upheld through the transition of strategic management and oversight of the company's daily operations to his son, Steven M. Kerscher.

Having grown from 90 to over 130 employees in the last 5 years, Lexi-Comp upholds a corporate culture focused on serving the needs of its employees and retaining exceptional talent. This philosophy earned the company recognition earlier this year as one of Northeast Ohio's 99 great workplaces for top talent.

For more information about Lexi-Comp, Inc. and career opportunities available, visit http://www.lexi.com/home/careers/.

About Lexi-Comp
Lexi-Comp, Inc. provides clinical information solutions to the healthcare industry, publishing point-of-care content utilized in both in-patient and out-patient settings. These advanced resources help improve patient outcomes, medication safety, and workflow efficiency. Pharmacotherapy knowledge areas include drug information for adult, pediatric, and geriatric populations; medication interactions; laboratory tests and diagnostic procedures; pharmacogenomics; poisoning and toxicology; dentistry; infectious diseases; and patient education. Over 500,000 clinicians worldwide access Lexi-Comp's content via the Internet, mobile devices, and through integration with health information systems. An extensive library of print titles is also available.

To learn more about Lexi-Comp's clinical information solutions, call 800.837.5394, 330.650.6506, or visit www.lexi.com.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3388174.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Lexi-Comp, Inc. Receives NorthCoast 99 Honor
2. Lexi-Comp, Inc. Offers Diagnosis and Disease Management Tool
3. All-Time Giant Great Receives Humanitarian of the Year Award
4. Rigel Receives Milestone Payment from Daiichi Sankyo for Cancer Ligase Target
5. CareData Solutions EHR v2.7, Receives Full CCHIT Certification
6. Allen Interactions Receives Silver Brandon Hall Learning Award
7. Heart Failure Patient Supported By DuraHeart™ Left-Ventricular Assist System Receives Successful Donor Transplant After Four Years On Device
8. Exposing the Double Standard of the Forgotten Cancer: Biggest Cancer Killer for Women and Men, Lung Cancer, Receives Least Research Funds
9. Neuralstem Receives Approval To Commence First ALS Stem Cell Trial at Emory ALS Center
10. Hebrew U. receives $5 million for research on leishmaniasis in Ethiopia
11. Boston University School of Medicines pulmonary center receives $1.4 million grant
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lexi-Comp, Inc. Receives Weatherhead 100 Honor
(Date:4/28/2017)... ... April 28, 2017 , ... Datta ... M.D. has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a ... Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain Foundation ... Leadership in Neurology Award (PLINA). The couple joins a prestigious list of past ... Walter Mondale, actor Michael J. Fox and former U.S. Attorney General Janet Reno. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
Breaking Medicine Technology: